After 30 years of research, pill for breast cancer approved for use
After six years of painful injections, Stephanie Walker has had enough.
Feb 8, 2023
0
4
After six years of painful injections, Stephanie Walker has had enough.
Feb 8, 2023
0
4
Josep Tabernero, Director of the Vall d'Hebron Institute of Oncology (VHIO), presented data from the international phase III SUNLIGHT study during an Oral Abstract Session at this week's American Society of Clinical Oncology's ...
Jan 23, 2023
0
8
A combination of two next-generation immunotherapy drugs has shown promising clinical activity in treating patients with refractory metastatic colorectal cancer, a disease which has not previously responded well to immunotherapies, ...
Jan 23, 2023
0
4
An estimated ninety percent of deaths from breast cancer are due to complications resulting from metastasis, a process in which cancer cells break away from where they first formed, travel through the blood or lymph circulatory ...
Jan 17, 2023
0
22
A new research paper titled "Impact of COVID-19 on the management of patients with metastatic melanoma" has been published in Oncotarget.
Jan 11, 2023
0
39
First-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-positive]) metastatic breast cancer (MBC), ...
Dec 20, 2022
0
0
Medicare costs for treatment of metastatic prostate cancer have risen sharply within the last 15 years—reflecting increased use of new medications under Medicare Part D, reports a study in Urology Practice.
Dec 20, 2022
0
0
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
Dec 16, 2022
0
29
The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer ...
Dec 8, 2022
0
2
A UCLA Jonsson Comprehensive Cancer Center researcher and collaborators in a multicenter study will present updated results and plans for further research on a new approach to treating advanced ER-positive/HER2-negative breast ...
Dec 7, 2022
0
33